Summary Keywords metabolite, biomarker, major depressive disorder, acetylcarnitine, remission status, drug treatment Citation Lee S, Mun S, Lee Y-R, Choi H, Joo E-J, Kang H-G and Lee J (2022) Discovery and validation of acetyl-L-carnitine in serum for diagnosis of major depressive disorder and remission status through metabolomic approach
Mitochondrial dysfunction has been linked to numerous diseases including RA, periodontitis, neurodegenerative diseases, diabetes, cancer, and obesity 20,21,22,23,24
GHK-Cu is scientifically proven to recharge these stem cells
Increased cholesterol release into bile can disrupt balance and promote gallstone formation
The risk of pancreatitis can be minimized by addressing and mitigating risk factors from previous episodes, regulating the rate of weight loss by adjusting the GLP-1 receptor agonist dose and the content and frequency of meals, closely monitoring patients during GLP-1 receptor agonist therapy, and implementing appropriate precautionary measures